Spero Therapeutics, Inc. (SPRO) has a market capitalization of $160.94M and trades at $2.78. The 52-week range is 0.505-3.22.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 18.5, Earnings Per Share (EPS) of $0.15, annual revenue of $59.62M.
The stock has a beta of 1.45, operates in the Healthcare sector.
